SpeechPathology.com Phone: 800-242-5183


eLuma Online Therapy - Own Boss - August 2024

What is Induced Laryngeal Obstruction (ILO) and how does it differ from Exercise Induced Laryngeal Obstruction (EILO)

Robert Brinton Fujiki, PhD, CCC-SLP

November 15, 2023

Share:

Question

What is Induced Laryngeal Obstruction (ILO) and how does it differ from Exercise Induced Laryngeal Obstruction (EILO)

Answer

Induced Laryngeal Obstruction (ILO) is characterized by trigger-induced laryngeal adduction that constricts the airway and causes dyspnea. ILO generally presents as inhalation difficulty and may include strider or wheezing. In addition to dyspnea, other symptoms of ILO may include a sensation of throat or chest tightness, cough, dysphonia, hyperventilation, and/or lightheadedness (Patel et al., 2015). Dyspnea is generally episodic, with sudden onset - often induced by an identifiable trigger such as physical exertion, stress, gastroesophageal reflux disease (GERD), scents, or exposure to an inhaled irritant (Sandage et al., 2022). Symptoms often resolve quickly upon exercise cessation or trigger removal.

ILO can be used as a general term for any type of induced laryngeal obstruction. Commonly used nomenclature, however, is generally based on symptom triggers. If dyspnea symptoms are triggered by physical exertion or exercise, the term Exercise Induced Laryngeal Obstruction (EILO) is used. The term ILO is used if symptoms are induced by non-physical exertion-related triggers (i.e., scents, irritants, stress, etc.).  ILO can be used generally and refer to non-exertion-reduced symptoms specifically. This can be a little confusing, and it might help to think of ILO as a general condition with two subtypes: ILO (obstruction triggered by irritants, scents, or stress) and EILO (obstruction triggered by physical activity or exercise).

This ATE is an excerpt from the course, 20Q: Induced Laryngeal Obstruction - An Overview for Speech-Language Pathologists, presented by Robert Brinton Fujiki, PhD, CCC-SLP.


robert brinton fujiki

Robert Brinton Fujiki, PhD, CCC-SLP

Robert Brinton Fujiki is a clinician scientist specializing in voice, resonance, and upper airway disorders – with particular reference to pediatric populations. He received his PhD at Purdue University and is currently a postdoctoral fellow at the University of Wisconsin-Madison. He is also a clinical speech-language pathologist in the voice and swallow and craniofacial anomaly clinics at American Family Children’s Hospital. His research interests include the diagnosis and treatment of voice disorders, induced laryngeal obstruction, and cleft palate in children. 

 


Related Courses

20Q: Induced Laryngeal Obstruction - An Overview for Speech-Language Pathologists
Presented by Robert Brinton Fujiki, PhD, CCC-SLP
Text

Presenter

Robert Brinton Fujiki, PhD, CCC-SLP
Course: #10761Level: Intermediate1 Hour
  'Organized information so it makes it easy to understand'   Read Reviews
The nature of induced laryngeal obstruction, including comorbidities and causes, and the speech-language pathologist’s role in evaluation and treatment of this disorder are described in this course. Current diagnostic and treatment practices and research updates pertaining to the condition are discussed.

20Q: Evaluation and Treatment of Speech/Resonance Disorders and Velopharyngeal Dysfunction
Presented by Ann W. Kummer, PhD, CCC-SLP
Text

Presenter

Ann W. Kummer, PhD, CCC-SLP
Course: #8729Level: Intermediate1 Hour
  'It was well organized'   Read Reviews
Children with speech and resonance disorders (hypernasality, hyponasality, and cul-de-sac resonance) and/or nasal emission present challenges for speech-language pathologists (SLPs) in all settings. This article will help participants to recognize resonance disorders and the characteristics of velopharyngeal dysfunction, and provide appropriate management.

20Q: Beyond the Swallow - Tracheostomy Tube and Ventilator Management
Presented by George Barnes, MS, CCC-SLP
Text

Presenter

George Barnes, MS, CCC-SLP
Course: #10056Level: Intermediate1 Hour
  'Great info!'   Read Reviews
This course addresses the various questions that may arise for the medical SLP involved in the care of patients with tracheostomy and/or mechanical ventilation. Topics include causes of respiratory failure, consequences of tracheostomy/ventilation, risk management related to intervention, and considerations for assessment and treatment of swallowing and communication, including the use of speaking valves.

20Q: Head and Neck Cancer for the Speech-Language Pathologist
Presented by Barbara Messing, PhD, CCC-SLP, BCS-S, FASHA
Text

Presenter

Barbara Messing, PhD, CCC-SLP, BCS-S, FASHA
Course: #10591Level: Advanced1 Hour
  'Thorough inform'   Read Reviews
Aspects of head and neck cancer (HNC) management relevant to the speech-language pathologist considering working with this population are described in this course. Specifically, HNC diagnosis and treatment, surgical and reconstructive options, communication and swallowing issues, treatment-related toxicities, and the impact on quality of life are addressed.

20Q: Putting Research into Practice: Application of Voice Science In the Therapy Room
Presented by Ryan Branski, PhD, Shirley Gherson, CCC-SLP
Text

Presenters

Ryan Branski, PhDShirley Gherson, CCC-SLP
Course: #9454Level: Advanced1 Hour
  'Really helpful overview, and the q and a format helpful as a reader'   Read Reviews
This course will address real-life scenarios therapists often come across when providing therapy to patients with voice disorders. Best referral practices and risk factors related to occupation and personality will be described. Evidence-based treatment strategies and principles - including for specific populations (e.g., pediatric, geriatric, performers) - are discussed, with particular focus on application of research.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.